Status:
NOT_YET_RECRUITING
Azole Susceptibility and Resistance Mechanisms Surveys in Pathogenic Fungi by the CARST-fungi (2023-2024)
Lead Sponsor:
Peking University First Hospital
Conditions:
Fungal Disease
Eligibility:
All Genders
Brief Summary
The China Antifungal Resistance Surveillance Trial (CARST-fungi) study, which has been starting in July 2019, is a multi-center, prospective, observational, and laboratory-based study of pathogenic fu...
Detailed Description
Invasive fungal diseases (IFDs) are life-threatening diseases with considerable morbidity and mortality, primarily occurring in immunocompromised and critically ill hosts. Azoles represent the most wi...
Eligibility Criteria
Inclusion
- fungal disease
Exclusion
- non-fungal disease
Key Trial Info
Start Date :
June 10 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06969703
Start Date
June 10 2025
End Date
September 30 2025
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University First Hospital
Beijing, China, 100034